UWE TITT to Humans
This is a "connection" page, showing publications UWE TITT has written about Humans.
Connection Strength
0.132
-
Analysis of the track- and dose-averaged LET and LET spectra in proton therapy using the geant4 Monte Carlo code. Med Phys. 2015 Nov; 42(11):6234-47.
Score: 0.010
-
Degradation of proton depth dose distributions attributable to microstructures in lung-equivalent material. Med Phys. 2015 Nov; 42(11):6425-32.
Score: 0.010
-
Comparison of MCNPX and Geant4 proton energy deposition predictions for clinical use. Phys Med Biol. 2012 Oct 21; 57(20):6381-93.
Score: 0.008
-
Adjustment of the lateral and longitudinal size of scanned proton beam spots using a pre-absorber to optimize penumbrae and delivery efficiency. Phys Med Biol. 2010 Dec 07; 55(23):7097-106.
Score: 0.007
-
Assessment of the accuracy of an MCNPX-based Monte Carlo simulation model for predicting three-dimensional absorbed dose distributions. Phys Med Biol. 2008 Aug 21; 53(16):4455-70.
Score: 0.006
-
Monte Carlo investigation of collimator scatter of proton-therapy beams produced using the passive scattering method. Phys Med Biol. 2008 Jan 21; 53(2):487-504.
Score: 0.006
-
Treatment-planning study of prostate cancer intensity-modulated radiotherapy with a Varian Clinac operated without a flattening filter. Int J Radiat Oncol Biol Phys. 2007 Aug 01; 68(5):1567-71.
Score: 0.006
-
Monte Carlo study of backscatter in a flattening filter free clinical accelerator. Med Phys. 2006 Sep; 33(9):3270-3.
Score: 0.005
-
Properties of unflattened photon beams shaped by a multileaf collimator. Med Phys. 2006 Jun; 33(6):1738-46.
Score: 0.005
-
MCNPX simulation of a multileaf collimator. Med Phys. 2006 Feb; 33(2):402-4.
Score: 0.005
-
Monte Carlo simulations of a nozzle for the treatment of ocular tumours with high-energy proton beams. Phys Med Biol. 2005 Nov 21; 50(22):5229-49.
Score: 0.005
-
Patient neutron dose equivalent exposures outside of the proton therapy treatment field. Radiat Prot Dosimetry. 2005; 115(1-4):154-8.
Score: 0.005
-
Design tools for proton therapy nozzles based on the double-scattering foil technique. Radiat Prot Dosimetry. 2005; 116(1-4 Pt 2):211-5.
Score: 0.005
-
Effect of boron compounds on the biological effectiveness of proton therapy. Med Phys. 2022 09; 49(9):6098-6109.
Score: 0.004
-
Nonhomologous End Joining Is More Important Than Proton Linear Energy Transfer in Dictating Cell Death. Int J Radiat Oncol Biol Phys. 2019 12 01; 105(5):1119-1125.
Score: 0.003
-
Comparison of Monte Carlo and analytical dose computations for intensity modulated proton therapy. Phys Med Biol. 2018 02 09; 63(4):045003.
Score: 0.003
-
Optimization of Monte Carlo particle transport parameters and validation of a novel high throughput experimental setup to measure the biological effects of particle beams. Med Phys. 2017 Nov; 44(11):6061-6073.
Score: 0.003
-
Differences in Normal Tissue Response in the Esophagus Between Proton and Photon Radiation Therapy for Non-Small Cell Lung Cancer Using In?Vivo Imaging Biomarkers. Int J Radiat Oncol Biol Phys. 2017 11 15; 99(4):1013-1020.
Score: 0.003
-
Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma. Radiother Oncol. 2016 12; 121(3):395-401.
Score: 0.003
-
Evaluation of a deterministic grid-based Boltzmann solver (GBBS) for voxel-level absorbed dose calculations in nuclear medicine. Phys Med Biol. 2016 06 21; 61(12):4564-82.
Score: 0.003
-
Validation of a track repeating algorithm for intensity modulated proton therapy: clinical cases study. Phys Med Biol. 2016 Apr 07; 61(7):2633-45.
Score: 0.003
-
Spatial mapping of the biologic effectiveness of scanned particle beams: towards biologically optimized particle therapy. Sci Rep. 2015 May 18; 5:9850.
Score: 0.002
-
Comprehensive analysis of proton range uncertainties related to patient stopping-power-ratio estimation using the stoichiometric calibration. Phys Med Biol. 2012 Jul 07; 57(13):4095-115.
Score: 0.002
-
Estimate of the uncertainties in the relative risk of secondary malignant neoplasms following proton therapy and intensity-modulated photon therapy. Phys Med Biol. 2010 Dec 07; 55(23):6987-98.
Score: 0.002
-
Stereotactic radiotherapy for lung cancer using a flattening filter free Clinac. J Appl Clin Med Phys. 2009 Jan 27; 10(1):14-21.
Score: 0.002
-
Monte Carlo study shows no significant difference in second cancer risk between 6- and 18-MV intensity-modulated radiation therapy. Radiother Oncol. 2009 Apr; 91(1):132-7.
Score: 0.002
-
Feasibility of a multigroup deterministic solution method for three-dimensional radiotherapy dose calculations. Int J Radiat Oncol Biol Phys. 2008 Sep 01; 72(1):220-7.
Score: 0.002
-
Density heterogeneities and the influence of multiple Coulomb and nuclear scatterings on the Bragg peak distal edge of proton therapy beams. Phys Med Biol. 2008 Sep 07; 53(17):4605-19.
Score: 0.002
-
Energy spectra, sources, and shielding considerations for neutrons generated by a flattening filter-free Clinac. Med Phys. 2008 May; 35(5):1906-11.
Score: 0.002
-
Reducing stray radiation dose to patients receiving passively scattered proton radiotherapy for prostate cancer. Phys Med Biol. 2008 Apr 21; 53(8):2131-47.
Score: 0.001
-
Monte Carlo calculations and measurements of absorbed dose per monitor unit for the treatment of uveal melanoma with proton therapy. Phys Med Biol. 2008 Mar 21; 53(6):1581-94.
Score: 0.001
-
Initial beam size study for passive scatter proton therapy. I. Monte Carlo verification. Med Phys. 2007 Nov; 34(11):4213-8.
Score: 0.001
-
A Monte Carlo model for out-of-field dose calculation from high-energy photon therapy. Med Phys. 2007 Sep; 34(9):3489-99.
Score: 0.001
-
Reduced neutron production through use of a flattening-filter-free accelerator. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):1260-4.
Score: 0.001
-
Determination of output factors for small proton therapy fields. Med Phys. 2007 Feb; 34(2):489-98.
Score: 0.001
-
Therapeutic step and shoot proton beam spot-scanning with a multi-leaf collimator: a Monte Carlo study. Radiat Prot Dosimetry. 2005; 115(1-4):164-9.
Score: 0.001